FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

37752311000001107: Larotrectinib sulfate (substance)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 28-Sep 2022. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    423391000001115 Larotrectinib sulfate en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
    423401000001117 Larotrectinib sulfate (substance) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Larotrectinib sulfate Is a Larotrectinib false Inferred relationship Existential restriction modifier
    Larotrectinib sulfate Is a Larotrectinib false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Larotrectinib 20mg/ml oral solution sugar free Has specific active ingredient False Larotrectinib sulfate Inferred relationship Existential restriction modifier
    Vitrakvi 20mg/ml oral solution sugar free (Bayer Plc) Has specific active ingredient False Larotrectinib sulfate Inferred relationship Existential restriction modifier
    Vitrakvi 20mg/ml oral solution sugar free (Bayer Plc) 100 ml 2 x 50ml bottles Has specific active ingredient False Larotrectinib sulfate Inferred relationship Existential restriction modifier
    Larotrectinib 20mg/ml oral solution sugar free 100 ml Has specific active ingredient False Larotrectinib sulfate Inferred relationship Existential restriction modifier
    Larotrectinib 20mg/ml oral solution Has specific active ingredient False Larotrectinib sulfate Inferred relationship Existential restriction modifier
    Vitrakvi 20mg/ml oral solution (Bayer Plc) Has specific active ingredient False Larotrectinib sulfate Inferred relationship Existential restriction modifier
    Larotrectinib 20mg/ml oral solution 100 ml Has specific active ingredient False Larotrectinib sulfate Inferred relationship Existential restriction modifier
    Vitrakvi 20mg/ml oral solution (Bayer Plc) 100 ml Has specific active ingredient False Larotrectinib sulfate Inferred relationship Existential restriction modifier
    Larotrectinib 100mg capsules Has specific active ingredient False Larotrectinib sulfate Inferred relationship Existential restriction modifier
    Larotrectinib 25mg capsules Has specific active ingredient False Larotrectinib sulfate Inferred relationship Existential restriction modifier
    Vitrakvi 25mg capsules (Bayer Plc) 56 capsule Has specific active ingredient False Larotrectinib sulfate Inferred relationship Existential restriction modifier
    Larotrectinib 100mg capsules 56 capsule Has specific active ingredient False Larotrectinib sulfate Inferred relationship Existential restriction modifier
    Vitrakvi 25mg capsules (Bayer Plc) Has specific active ingredient False Larotrectinib sulfate Inferred relationship Existential restriction modifier
    Larotrectinib 25mg capsules 56 capsule Has specific active ingredient False Larotrectinib sulfate Inferred relationship Existential restriction modifier
    Vitrakvi 100mg capsules (Bayer Plc) Has specific active ingredient False Larotrectinib sulfate Inferred relationship Existential restriction modifier
    Vitrakvi 100mg capsules (Bayer Plc) 56 capsule Has specific active ingredient False Larotrectinib sulfate Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start